{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:38:34Z","timestamp":1793252314759,"version":"4.5.0"},"reference-count":19,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["etj.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the final diagnosis and clinical outcome of patients referred to endocrinology in our district general hospital with biochemical isolated central hypothyroidism (CeH), and whether there is an association between this biochemical picture and treatment with antidepressant and antipsychotic medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective observational study of patients referred to endocrinology with unexplained biochemical isolated CeH over a 5-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 29 patients included in the study, 4 were found to have a partially empty or empty sella and 1 to have a bulky pituitary gland which was deemed to be an incidental radiological finding. No patients had any clinically significant pathology. On reviewing their medications, 18\/29 (62%) were found to be on psychotropic medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study suggests a relationship between patients on psychotropic medications and biochemical isolated CeH, an association only described in a very limited amount of literature prior to this. The mechanism behind this may be suppression of TSH secretion via antagonism of the dopamine-serotoninergic pathway. Determining a correlation between psychotropic medications and isolated CeH could lead to the avoidance of further radiological investigations and unnecessary anxiety for patients. However, a larger observational study is needed to provide further evidence to support\/refute our finding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-21-0119","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T11:09:42Z","timestamp":1644491382000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":14,"title":["Central hypothyroidism related to antipsychotic and antidepressant medications: an observational study and literature review"],"prefix":"10.1530","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2432-6449","authenticated-orcid":true,"given":"Frederick","family":"Keen","sequence":"first","affiliation":[{"name":"Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Chalishazar","sequence":"additional","affiliation":[{"name":"Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Mitchem","sequence":"additional","affiliation":[{"name":"Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Dodd","sequence":"additional","affiliation":[{"name":"Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kalhan","sequence":"additional","affiliation":[{"name":"Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Clinical Endocrinology and Metabolism","article-title":"Clinical Review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges","volume":"97","author":"Persani","year":"2012","unstructured":"Persani LClinical Review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. Journal of Clinical Endocrinology and Metabolism201297 3068\u20133078. (https:\/\/doi.org\/10.1210\/jc.2012-1616)"},{"key":"bib2","series-title":"European Thyroid Journal","first-page":"225","article-title":"2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism","volume":"7","author":"Persani","year":"2018","unstructured":"Persani LBrabant GDattani MBonomi MFeldt-Rasmussen UFliers EGruters AMaiter DSchoenmakers Nvan Trotsenburg ASP. 2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism. European Thyroid Journal20187225\u2013237. (https:\/\/doi.org\/10.1159\/000491388)"},{"key":"bib3","series-title":"Oxford Handbook of Endocrinology and Diabetes","article-title":"Pituitary","author":"Wass","year":"2014","unstructured":"Wass JOwen K. Pituitary. In Oxford Handbook of Endocrinology and Diabetes, 3rd ed., Chapter 2, pp. 122, 194. Oxford University Press, 2014."},{"key":"bib4","series-title":"Clinical Neuropharmacology","first-page":"248","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","author":"Bou Khalil","year":"2011","unstructured":"Bou Khalil RRicha S. Thyroid adverse effects of psychotropic drugs: a review. Clinical Neuropharmacology201134248\u2013255. (https:\/\/doi.org\/10.1097\/WNF.0b013e31823429a7)"},{"key":"bib5","series-title":"Journal of Clinical and Translational Endocrinology","first-page":"5","article-title":"Less known aspects of central hypothyroidism: part 2 \u2013 congenital etiologies","volume":"14","author":"Benvenga","year":"2018","unstructured":"Benvenga SKlose MVita RFeldt-Rasmussen U. Less known aspects of central hypothyroidism: part 2 \u2013 congenital etiologies. Journal of Clinical and Translational Endocrinology2018145\u201311. (https:\/\/doi.org\/10.1016\/j.jcte.2018.09.004)"},{"key":"bib6","series-title":"Best Practice and Research: Clinical Endocrinology and Metabolism","first-page":"793","article-title":"Drugs that suppress TSH or cause central hypothyroidism","volume":"23","author":"Haugen","year":"2009","unstructured":"Haugen BRDrugs that suppress TSH or cause central hypothyroidism. Best Practice and Research: Clinical Endocrinology and Metabolism200923793\u2013800. (https:\/\/doi.org\/10.1016\/j.beem.2009.08.003)"},{"key":"bib7","series-title":"New England Journal of Medicine","first-page":"749","article-title":"Drug effects on the thyroid","volume":"381","author":"Burch","year":"2019","unstructured":"Burch HBDrug effects on the thyroid. New England Journal of Medicine2019381749\u2013761. (https:\/\/doi.org\/10.1056\/NEJMra1901214)"},{"key":"bib8","series-title":"Toxicology and Applied Pharmacology","first-page":"127","article-title":"Relationship between psychotropic drugs and thyroid function: a review","volume":"149","author":"Sauvage","year":"1998","unstructured":"Sauvage MFMarquet PRousseau ARaby CBuxeraud JLach\u00e2tre G. Relationship between psychotropic drugs and thyroid function: a review. Toxicology and Applied Pharmacology1998149127\u2013135. (https:\/\/doi.org\/10.1006\/taap.1998.8367)"},{"key":"bib9","series-title":"European Neuropsychopharmacology","first-page":"139","article-title":"The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: a systematic review and meta-analysis","volume":"33","author":"Caye","year":"2020","unstructured":"Caye APilz LKMaia ALHidalgo MPFurukawa TAKieling C. The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: a systematic review and meta-analysis. European Neuropsychopharmacology202033139\u2013145. (https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.011)"},{"key":"bib10","series-title":"Critical Reviews in Neurobiology","first-page":"45","article-title":"Thyroid hormones, the brain, and affective disorders","volume":"8","author":"Joffe","year":"1994","unstructured":"Joffe RTSokolov ST. Thyroid hormones, the brain, and affective disorders. Critical Reviews in Neurobiology1994845\u201363."},{"key":"bib11","series-title":"International Journal of Neuropsychopharmacology","first-page":"149","article-title":"Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research","volume":"3","author":"Baumgartner","year":"2000","unstructured":"Baumgartner AThyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. International Journal of Neuropsychopharmacology20003149\u2013165. (https:\/\/doi.org\/10.1017\/S1461145700001887)"},{"key":"bib12","series-title":"Journal of Psychiatry and Neuroscience","first-page":"383","article-title":"Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors","volume":"29","author":"Gitlin","year":"2004","unstructured":"Gitlin MAltshuler LLFrye MASuri RHuynh ELFairbanks LBauer MKorenman S. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. Journal of Psychiatry and Neuroscience200429383\u2013386."},{"key":"bib13","series-title":"Brain and Behavior","first-page":"89","article-title":"Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study","volume":"3","author":"Abulseoud","year":"2013","unstructured":"Abulseoud OAGitlin MAltshuler LFrye MA. Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study. Brain and Behavior2013389\u201394. (https:\/\/doi.org\/10.1002\/brb3.109)"},{"key":"bib14","series-title":"Pharmacopsychiatry","first-page":"237","article-title":"Quetiapine-associated hypothyroidism in young female patients: a report of three cases","volume":"43","author":"Poutanen","year":"2010","unstructured":"Poutanen OIso-Koivisto ETy\u00f6l\u00e4j\u00e4rvi MLeinonen E. Quetiapine-associated hypothyroidism in young female patients: a report of three cases. Pharmacopsychiatry201043237\u2013239. (https:\/\/doi.org\/10.1055\/s-0030-1261880)"},{"key":"bib15","series-title":"Journal of the American Academy of Child and Adolescent Psychiatry","first-page":"575","article-title":"Quetiapine-induced central hypothyroidism","volume":"59","author":"Zenno","year":"2020","unstructured":"Zenno ALeschek E. Quetiapine-induced central hypothyroidism. Journal of the American Academy of Child and Adolescent Psychiatry202059575\u2013576. (https:\/\/doi.org\/10.1016\/j.jaac.2020.01.018)"},{"key":"bib16","article-title":"Product monograph including patient medication information: Seroquel","year":"2021","unstructured":"AstraZeneca Canada. Product monograph including patient medication information: Seroquel. Mississauga, Ontario: AstraZeneca Canada, 2021. (available at: https:\/\/www.astrazeneca.ca\/content\/dam\/az-ca\/downloads\/productinformation\/seroquel-product-monograph-en.pdf)"},{"key":"bib17","series-title":"Schizophrenia Bulletin","first-page":"S205","article-title":"T229. Antipsychotic drug use and thyroid function in patients with severe mental disorders","volume":"44","author":"Iversen","year":"2018","unstructured":"Iversen TSteen NEBirkeland KIM\u00f8rch RHReponen EJAnderssen JFR\u00f8devand LMelle IAndreassen OAMolden ET229. Antipsychotic drug use and thyroid function in patients with severe mental disorders. Schizophrenia Bulletin201844S205\u2013S206. (https:\/\/doi.org\/10.1093\/schbul\/sby016.505)"},{"key":"bib18","series-title":"Best Practice and Research: Clinical Endocrinology and Metabolism","first-page":"745","article-title":"Pitfalls in the measurement and interpretation of thyroid function tests","volume":"27","author":"Koulouri","year":"2013","unstructured":"Koulouri OMoran CHalsall DChatterjee KGurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Practice and Research: Clinical Endocrinology and Metabolism201327745\u2013762. (https:\/\/doi.org\/10.1016\/j.beem.2013.10.003)"},{"key":"bib19","series-title":"Endocrine Reviews","first-page":"830","article-title":"Interferences with thyroid function immunoassays: clinical implications and detection algorithm","volume":"39","author":"Favresse","year":"2018","unstructured":"Favresse JBurlacu MCMaiter DGruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocrine Reviews201839830\u2013850. (https:\/\/doi.org\/10.1210\/er.2018-00119)"}],"container-title":["European Thyroid Journal"],"original-title":[],"link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/11\/2\/ETJ-21-0119.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/11\/2\/ETJ-21-0119.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/11\/2\/ETJ-21-0119.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:51:32Z","timestamp":1784555492000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/etj\/article\/2833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":19,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/etj-21-0119","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}